Skip to contentSkip to Braille Studio

Library / Laws / 113th Congress / House Bills / H.R. 4918

H.R. 4918

To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.

Print stageDateSize⠃
Introduced in House2014-06-191.4K⠃⠗⠋